Biodesix Inc (BDSX): Total Assets
$87.48M
As of 2025-12-31
$95.33M
As of 2026-06-30
-2.0%
3-year compound annual growth
-6.3%
5-year compound annual growth
| Period ended | Total Assets | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $87.48M | -10.0% | 2026-02-26, Balance as of period end |
| 2024-12-31 | $97.24M | -1.9% | 2026-02-26, Balance as of period end |
| 2023-12-31 | $99.10M | +6.7% | 2025-03-03, Balance as of period end |
| 2022-12-31 | $92.91M | +22.1% | 2024-03-01, Balance as of period end |
| 2021-12-31 | $76.10M | -37.1% | 2023-03-06, Balance as of period end |
| 2020-12-31 | $121.07M | +168.8% | 2022-03-14, Balance as of period end |
| 2019-12-31 | $45.03M | n/a | 2021-03-16, Balance as of period end |
Total Assets at similar companies
| Company | Year ended | Total Assets | Change YoY |
|---|---|---|---|
| Biodesix Inc (BDSX) | 2025-12-31 | $87.48M | -10.0% |
| Personalis, Inc. (PSNL) | 2025-12-31 | $334.16M | +23.6% |
| Exagen Inc. (XGN) | 2025-12-31 | $58.02M | +29.8% |
| GRAIL, Inc. (GRAL) | 2025-12-31 | $2.92B | -2.1% |
| American Shared Hospital Services (AMS) | 2025-12-31 | $55.48M | -7.8% |
| BillionToOne, Inc. (BLLN) | 2025-12-31 | $632.65M | +109.4% |
| Fulgent Genetics, Inc. (FLGT) | 2025-12-31 | $1.21B | -0.5% |
| Castle Biosciences Inc (CSTL) | 2025-12-31 | $578.56M | +8.9% |
| CareDx, Inc. (CDNA) | 2025-12-31 | $413.23M | -15.8% |
Compare BDSX, PSNL, XGN, GRAL side by side · Screen every company in Services-Medical Laboratories ↗